Efficacy and safety of lazertinib in the treatment of EGFRmutated non-small cell lung cancer: a systematic review

被引：0
|
作者：
Gunawan, J. Evangeline [1 ]
机构：
[1] Pelita Harapan Univ, Dept Internal Med, Fac Med, Tangerang, Indonesia
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.07.412
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P38-2
引用
收藏
页码：S1377 / S1377
页数：1
相关论文
共 50 条
  • [21] The safety of afatinib for the treatment of non-small cell lung cancer
    Barron, Feliciano
    de la Torre-Vallejo, Martha
    Luz Luna-Palencia, Rosa
    Cardona, Andres F.
    Arrieta, Oscar
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (11) : 1563 - 1572
  • [22] Safety of gefitinib in non-small cell lung cancer treatment
    Hsiue, Emily Han-Chung
    Lee, Jih-Hsiang
    Lin, Chia-Chi
    Yang, James Chih-Hsin
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (07) : 993 - 1000
  • [23] Efficacy and safety of angiogenesis inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis
    Hong, Shaodong
    Tan, Min
    Wang, Shouzheng
    Luo, Shengyuan
    Chen, Yue
    Zhang, Li
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (05) : 909 - 921
  • [24] Efficacy and Safety of Amivantamab in Advanced or Metastatic EGFR-Mutant Non-Small Cell Lung Cancer: A Systematic Review
    Papassotiriou, Ionas
    Kapogiannatos, Antonios
    Makatsoris, Christos
    Bakogeorgou, Sabrina
    Mantogiannakou, Ioanna
    Roussou, Emmanouela
    Souras, Georgios
    Liakas, Dimitris
    Sergentanis, Theodoros N.
    Gavriatopoulou, Maria
    Ntanasis-Stathopoulos, Ioannis
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (18)
  • [25] Efficacy and safety of angiogenesis inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis
    Shaodong Hong
    Min Tan
    Shouzheng Wang
    Shengyuan Luo
    Yue Chen
    Li Zhang
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 909 - 921
  • [26] Non-small cell lung cancer therapy: safety and efficacy in the elderly
    Glotzer, Owen S.
    Fabian, Thomas
    Chandra, Anurag
    Bakhos, Charles T.
    DRUG HEALTHCARE AND PATIENT SAFETY, 2013, 5 : 113 - 121
  • [27] Efficacy and safety of Navelbine® oral in non-small cell lung cancer
    Zatloukal, P
    Jassem, J
    Depierre, A
    Ramlau, R
    Mlodkowska, HK
    Krawczyk, K
    Krzakowski, M
    Lemarié, E
    O'Brien, M
    His, P
    Lefresne-Soulas, F
    LUNG CANCER: CURRENT TOPICS, 2001, : 353 - 357
  • [28] The safety and efficacy of atezolizumab in small cell lung cancer: a systematic review
    Perdana, A. W. P.
    Antara, G. A. A. P.
    Phielibert, E.
    Sabran, M. Z.
    Kurniawan, A.
    Huang, I.
    ANNALS OF ONCOLOGY, 2024, 35 : S1380 - S1380
  • [29] A systematic review of non-small cell lung cancer treatment-related cardiotoxicity
    Chan, Stefanie Ho Yi
    Khatib, Yasmin
    Webley, Sherael
    Layton, Deborah
    Salek, Sam
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 129 - 129
  • [30] Consistency of recommendations for the diagnosis and treatment of non-small cell lung cancer: a systematic review
    Zhang, Zhe
    Yang, Sen
    Ma, Yanfang
    Zhou, Hanqiong
    Wu, Xuan
    Han, Jing
    Hou, Jiabao
    Hao, Lidan
    Spicer, Jonathan D.
    Koh, Young Wha
    Provencio, Mariano
    Reguart, Noemi
    Mitsudomi, Tetsuya
    Wang, Qiming
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (06) : 2715 - +
12345